Full Text (PDF)
Original Article

Comparative Study of Lipid Profile in Women Using Oral Contraceptive Pills Versus Non Oral Contraceptive Pills Users in Reproductive Age Group

Kamlesh Kumar, Department of Pathology and Blood Bank., Mahamaya Rajkiya Allopathic Medical College, Akabarpur, Ambedkar Nagar, Uttar Pradesh Pin 224227 , India. , Jagjeewan Ram* , Kamlesh Kumar** , Manoj Kumar Gupta***

Author Information

Licence:




Indian Journal of Pathology: Research and Practice 6(4 (Part-2)):p 1037-1040, Oct-Dec 2017. | DOI: DOI: http://dx.doi.org/10.21088/ijprp.2278.148X.6417.35

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Population explosion has posed a serious threat to the progress and survival of mankind. The Oral contraceptive pills (OCPs) quickly have become the most effective, acceptable and reversible contraceptive. OCPs contain an estrogen and progesterone. Serious side effects of OCPS are cardiovascular diseases such as myocardial infarction, thrombosis, cerebral hemorrhage, and arteriosclerosis. Many epidemiological studies have clearly indicated that arteriosclerosis and myocardial infarction are closely linked to an impaired lipid and lipoprotein metabolism and from such studies it’s also documented that treatment of the lipoproteinemia will reduce the risk of coronary heart disease.

 

Keywords: Oral Contraceptive Pills (OCPs), High Density Lipoprotein Cholesterol (HDL); Low Density Lipoprotein Cholesterol (LDL); Total Cholesterol (TC) and Triglycerides (TG). 


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI: DOI: http://dx.doi.org/10.21088/ijprp.2278.148X.6417.35

Keywords


Article Level Metrics

Last Updated

Sunday 12 July 2026, 13:53:18 (IST)


2018

Accesses

3
434
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share